Deropharma SRL
Deropharma reported total assets of 29,143 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Jun 2026).
The score of Deropharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Deropharma's annual accounts
| 2025 | |
|---|---|
| Net result | 14,263 € |
| Equity | 18,263 € |
| Cash | 17,853 € |
| EBITDA | 18,590 € |
| Total assets | 29,143 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jun 2026
Deropharma's financial analysis
- Solvency62.7%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Deropharma
Deropharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1021.522.440
- VAT number
- BE1021522440
- Peppol
- Registered · 0208:1021522440 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Mar 2025
- Registered office
- 1410 Waterloo
- Latest accounts
- 2025 · filed on 24 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Deropharma (SRL) has been based in Waterloo since 2025, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 14,263 € and equity of 18,263 €; its revenue is not published. Its solvency stands at 62.7%, above the median of its sector (41.5%).
Companies similar to Deropharma
Companies in the same business, of comparable size and area, outside its group.
- Anne Longueville Retail sale of pharmaceutical products Écaussinnes · balance sheet 29,378 €
- BLAIRVACQ Jean François Retail sale of pharmaceutical products Waremme · balance sheet 29,415 €
- Espace Medical Jumet Retail sale of pharmaceutical products Charleroi · balance sheet 29,613 €
- AB Society Retail sale of pharmaceutical products Saint-Ghislain · balance sheet 31,595 €
- Goed Aalter Retail sale of pharmaceutical products Anderlecht · balance sheet 31,881 €
- Lorena Boulanger Pharma Retail sale of pharmaceutical products Chapelle-lez-Herlaimont · balance sheet 32,165 €
- VENI Retail sale of pharmaceutical products Meise · balance sheet 32,367 €
- NL Pharma Retail sale of pharmaceutical products Florennes · balance sheet 33,758 €
Frequently asked questions about Deropharma
What is the revenue of Deropharma?
Deropharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Deropharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1021522440 for Deropharma, if the company is VAT-registered. Its company number (CBE) is 1021.522.440.
Where is the registered office of Deropharma?
According to the CBE register, the registered office of Deropharma is in 1410 Waterloo.
What is the equity of Deropharma?
At the close of the 2025 financial year, the equity of Deropharma amounts to 18,263 €, a solvency of 62.7% of total assets.
Who manages Deropharma?
The register lists 1 active mandates at Deropharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Deropharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →